How does dietary carbohydrate influence the formation of an atherogenic lipoprotein phenotype?

Not Applicable

Completed

• Conditions: Topic: Diabetes Research Network, Primary Care Research Network for England; Subtopic: Other; Disease: Cardiovascular disease; Nutritional, Metabolic, Endocrine; Dietary carbohydrate

• Registration Number: ISRCTN09001687
• Lead Sponsor: Biotechnology and Biological Sciences Research Council (BBSRC) (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-19
• Study Completion: 2011-09-01
• Last Update Posted: 6 June 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

Not provided at time of registration

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Formation of high- and low-risk lipoprotein phenotypes

Secondary Outcome Measures

Name	Time	Method
<br> 1. LDL kinetics, with a focus on the formation of small dense LDL<br> 2. Sources of liver fat<br> 3. Whether VLDL-TG is derived from increased DNL and/or systemically derived NEFA<br> 4. VLDL kinetics, with focus on differential effects on the synthesis of VLDL-TG and VLDL-apoB<br>